. Author manuscript; available in PMC: 2020 Dec 1.

Published in final edited form as: Am J Transplant. 2019 Jul 25;19(12):3284–3298. doi: 10.1111/ajt.15505

Table 2.

Summary of Respiratory Tract Infections

Infection Type	# of Episode	# of Subject
Any infection including CARV, Bacterial, Viral, Fungal, Mycobacterial, and Protozoan	416	57
At Least one infection of CARV, Bacterial, or Fungal LRTI and Respiratory (Unspecified)	268	56
No infection at all	--	4 ^*

CARV	156	50
Bacterial (LRTI and Respiratory (Unspecified)	117 (103 with LRTI only)	41 (38 with LRTI only)
Fungal (LRTI and Respiratory (Unspecified)	39	25
Bacterial or Fungal (LRTI and Respiratory (Unspecified)	140	46

CARV and either Bacterial or Fungal (LRTI and Respiratory (Unspecified) at the same time	37	25 ^**
CARV and Bacterial but no Fungal (LRTI and Respiratory (Unspecified) at the same time	27	21 ^**
CARV and Fungal but no Bacterial (LRTI and Respiratory (Unspecified) at the same time	8	8 ^**
3 infections at the same time	2	2 ^**

CARV and Neither Bacterial or Fungal (LRTI and Respiratory (Unspecified) at the same time	119	46 ^***
Bacterial or Fungal (LRTI and Respiratory (Unspecified) but No CARV at the same time	112	42 ^***
Bacterial and Fungal (LRTI and Respiratory (Unspecified) but No CARV at the same time	8	5 ^***

3 subjects who did not have any infection died early between 1-27 days post-transplant due to the primary graft failures and cardiac failure. 1 subject completed the study without any infection and not meeting composite endpoint.

^**

The count reflects the number of unique subjects with CARV, LRT bacterial or fungal infections, regardless of type.

^***

Subjects may be counted in more than one row if the subject experienced multiple types of infection.